The season is over for Washington Wizards forward Cam Whitmore, as he recovers from a frightening injury setback. “Washington ...
Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...
The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...
Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...
Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal. Penumbra is focused on developing technologies for challenging medical conditions such as ...
Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...
The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...
Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as ...
Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...
Analysis from a Columbia and Rutgers Health team finds long-term antipsychotic use rose 65% from 2015 to 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results